Eradication of hepatitis C virus infection in thalassemia patients in Iran using various treatment strategies
Background: Chronic hepatitis C virus (HCV) infection is considered as one of the leading causes of liver disease in thalassemic patients in Iran. Over 40% of the mortality in these patients is related to HCV. Objectives: The present study aimed at estimating HCV prevalence in thalassemic patients i...
Saved in:
Main Authors: | Meisam Moghimbeygi (Author), Seyed Moayed Alavian (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection of Hepatitis C Virus RNA in blood and saliva of transfusion-dependent thalassemia patients diagnosed with Hepatitis C
by: Behzad Hooshmand, et al.
Published: (2018) -
The role of the Primary Healthcare Network in Iran in hepatitis C virus elimination by 2030
by: Masoud Behzadifar, et al.
Published: (2018) -
Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis
by: Abdolhalim Rajabi, et al.
Published: (2021) -
Seroprevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency Virus in Patients with Thalassemia Major in Zahedan, Southeast of Iran
by: Hosnie Hoseini
Published: (2019) -
Molecular Epidemiology of Hepatitis C Virus Genotypes in Patients with Thalassemia Major in Golestan Province, Iran
by: sareh Zhand, et al.
Published: (2017)